CAPA

Study at a Glance

Estimated Time Commitment

To be discussed

Eligibility

COVID positive, requiring mechanical ventilation

Diagnosis Required

Confirmed COVID diagnosis requiring mechanical ventilation

Diseases Being Studied

SARS-CoV-2
Location: San Antonio, TX

Sponsor: CDC and Astellas Pharma

Coordinating Center/CRO: University of Alabama, Birmingham

Primary Objective: Observational to determine cumulative incidence of Pulmonary aspergillosis in patients requiring mechanical ventilation for 72 hours or more

Study drugs N/A

Sample size: 400

Local enrollment: 3

Meet Your Clinical Research Team

Contact us

Principal Investigator: Consent LAR

For questions on this study, please contact Dr. Barbara Taylor